B350 SNS-032, a Potent and Selective CDK2, 7 and 9...

Clinical Lymphoma & Myeloma 2009 / 2 Vol. 9

B350 SNS-032, a Potent and Selective CDK2, 7 and 9 Inhibitor, Demonstrates Preclinical Activity in Human Multiple Myeloma

David, E, Lonial, S, Taverna, P, Stewart, AK, Trudel, S, Sebag, M, Li, ZH, Shi, C-X, Bergsagel, PL, Chesi, M, Hazlehurst, L, Mitsiades, C, Hawtin, R, Fox, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70712-0
Date:
February, 2009
File:
PDF, 116 KB
english, 2009
Conversion to is in progress
Conversion to is failed